vs
Side-by-side financial comparison of IDEAYA Biosciences, Inc. (IDYA) and RADIAN GROUP INC (RDN). Click either name above to swap in a different company.
RADIAN GROUP INC is the larger business by last-quarter revenue ($300.5M vs $207.8M, roughly 1.4× IDEAYA Biosciences, Inc.). IDEAYA Biosciences, Inc. runs the higher net margin — 57.4% vs 51.5%, a 5.8% gap on every dollar of revenue. IDEAYA Biosciences, Inc. produced more free cash flow last quarter ($142.2M vs $115.7M).
IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.
Radian Group Inc. is a mortgage insurance company with a suite of mortgage, risk, real estate, and title services.
IDYA vs RDN — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $207.8M | $300.5M |
| Net Profit | $119.2M | $154.8M |
| Gross Margin | — | — |
| Operating Margin | 52.2% | 76.2% |
| Net Margin | 57.4% | 51.5% |
| Revenue YoY | — | 2.7% |
| Net Profit YoY | 330.1% | 4.4% |
| EPS (diluted) | $1.33 | $1.11 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $300.5M | ||
| Q3 25 | $207.8M | $303.2M | ||
| Q2 25 | — | $298.6M | ||
| Q1 25 | — | $294.8M | ||
| Q4 24 | — | $292.7M | ||
| Q3 24 | $0 | $313.4M | ||
| Q2 24 | $0 | $298.6M | ||
| Q1 24 | $0 | $301.7M |
| Q4 25 | — | $154.8M | ||
| Q3 25 | $119.2M | $141.4M | ||
| Q2 25 | — | $141.8M | ||
| Q1 25 | — | $144.6M | ||
| Q4 24 | — | $148.3M | ||
| Q3 24 | $-51.8M | $151.9M | ||
| Q2 24 | $-52.8M | $151.9M | ||
| Q1 24 | $-39.6M | $152.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 97.2% | ||
| Q1 25 | — | 97.0% | ||
| Q4 24 | — | 96.6% | ||
| Q3 24 | — | 97.0% | ||
| Q2 24 | — | 96.8% | ||
| Q1 24 | — | 96.9% |
| Q4 25 | — | 76.2% | ||
| Q3 25 | 52.2% | 65.5% | ||
| Q2 25 | — | 58.6% | ||
| Q1 25 | — | 63.9% | ||
| Q4 24 | — | 83.6% | ||
| Q3 24 | — | 68.4% | ||
| Q2 24 | — | 63.0% | ||
| Q1 24 | — | 65.8% |
| Q4 25 | — | 51.5% | ||
| Q3 25 | 57.4% | 46.7% | ||
| Q2 25 | — | 47.5% | ||
| Q1 25 | — | 49.0% | ||
| Q4 24 | — | 50.7% | ||
| Q3 24 | — | 48.5% | ||
| Q2 24 | — | 50.9% | ||
| Q1 24 | — | 50.5% |
| Q4 25 | — | $1.11 | ||
| Q3 25 | $1.33 | $1.03 | ||
| Q2 25 | — | $1.02 | ||
| Q1 25 | — | $0.98 | ||
| Q4 24 | — | $0.97 | ||
| Q3 24 | $-0.60 | $0.99 | ||
| Q2 24 | $-0.68 | $0.98 | ||
| Q1 24 | $-0.53 | $0.98 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $786.9M | $24.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.1B | $4.8B |
| Total Assets | $1.2B | $8.1B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $24.8M | ||
| Q3 25 | $786.9M | $15.3M | ||
| Q2 25 | — | $22.1M | ||
| Q1 25 | — | $24.2M | ||
| Q4 24 | — | $19.2M | ||
| Q3 24 | $920.0M | $28.1M | ||
| Q2 24 | $701.7M | $13.8M | ||
| Q1 24 | $698.8M | $27.0M |
| Q4 25 | — | $4.8B | ||
| Q3 25 | $1.1B | $4.7B | ||
| Q2 25 | — | $4.5B | ||
| Q1 25 | — | $4.6B | ||
| Q4 24 | — | $4.6B | ||
| Q3 24 | $1.2B | $4.7B | ||
| Q2 24 | $931.7M | $4.5B | ||
| Q1 24 | $935.3M | $4.4B |
| Q4 25 | — | $8.1B | ||
| Q3 25 | $1.2B | $8.2B | ||
| Q2 25 | — | $9.6B | ||
| Q1 25 | — | $8.8B | ||
| Q4 24 | — | $8.7B | ||
| Q3 24 | $1.2B | $8.4B | ||
| Q2 24 | $973.7M | $8.1B | ||
| Q1 24 | $961.5M | $7.8B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $142.2M | $119.9M |
| Free Cash FlowOCF − Capex | $142.2M | $115.7M |
| FCF MarginFCF / Revenue | 68.4% | 38.5% |
| Capex IntensityCapex / Revenue | 0.0% | 1.4% |
| Cash ConversionOCF / Net Profit | 1.19× | 0.77× |
| TTM Free Cash FlowTrailing 4 quarters | $13.5M | $-174.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $119.9M | ||
| Q3 25 | $142.2M | $358.4M | ||
| Q2 25 | — | $-713.3M | ||
| Q1 25 | — | $67.8M | ||
| Q4 24 | — | $-663.6M | ||
| Q3 24 | $-49.2M | $-237.9M | ||
| Q2 24 | $-32.9M | $-207.3M | ||
| Q1 24 | $-43.8M | $51.0M |
| Q4 25 | — | $115.7M | ||
| Q3 25 | $142.2M | $357.6M | ||
| Q2 25 | — | $-714.6M | ||
| Q1 25 | — | $66.6M | ||
| Q4 24 | — | $-665.1M | ||
| Q3 24 | $-49.7M | $-239.2M | ||
| Q2 24 | $-33.9M | $-208.3M | ||
| Q1 24 | $-45.1M | $49.5M |
| Q4 25 | — | 38.5% | ||
| Q3 25 | 68.4% | 117.9% | ||
| Q2 25 | — | -239.4% | ||
| Q1 25 | — | 22.6% | ||
| Q4 24 | — | -227.3% | ||
| Q3 24 | — | -76.3% | ||
| Q2 24 | — | -69.8% | ||
| Q1 24 | — | 16.4% |
| Q4 25 | — | 1.4% | ||
| Q3 25 | 0.0% | 0.3% | ||
| Q2 25 | — | 0.4% | ||
| Q1 25 | — | 0.4% | ||
| Q4 24 | — | 0.5% | ||
| Q3 24 | — | 0.4% | ||
| Q2 24 | — | 0.4% | ||
| Q1 24 | — | 0.5% |
| Q4 25 | — | 0.77× | ||
| Q3 25 | 1.19× | 2.53× | ||
| Q2 25 | — | -5.03× | ||
| Q1 25 | — | 0.47× | ||
| Q4 24 | — | -4.47× | ||
| Q3 24 | — | -1.57× | ||
| Q2 24 | — | -1.36× | ||
| Q1 24 | — | 0.34× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
